false
0000754811
0000754811
2023-03-01
2023-03-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(d) Of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 1, 2023
U.S. GLOBAL INVESTORS, INC.
(Exact name of registrant as specified in its charter)
|
Texas
|
0-13928
|
74-1598370
|
|
(State of other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
7900 Callaghan Road, San Antonio, Texas 78229
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 210-308-1234
| |
|
|
| |
(Former name or former address, if changed since last report) |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Class A common stock, $0.25 par value per share
|
GROW
|
NASDAQ Capital Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter)
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On March 1, 2023, U.S. Global Investors, Inc. (the “Company”) reached a determination to restate the Company’s consolidated financial statements and related disclosures for the fiscal year ended June 30, 2022, and for the three months ended September 30, 2022. For additional information about the restatement and related matters, please see Item 4.02 below.
As previously disclosed, the Company did not file its Quarterly Report on Form 10-Q for the three and six months ended December 31, 2022, by the prescribed due date. The Company’s delay in completing such filing is due to additional time needed by the Company to determine the fair value on certain corporate investments, which is complete. Additionally, errors have been detected in fair value calculations performed by a third party on certain corporate investments, and the Company is taking the necessary time to thoroughly and properly reflect the corrected valuations in the June 30, 2022, Form 10-K restatement, and after that is complete, will take the necessary time to thoroughly and properly reflect the corrected valuations in the September 30, 2022, Form 10-Q restatement. The Company is working diligently to file its restated Form 10-K/A-2 for the fiscal year ended June 30, 2022, Form 10-Q/A for the three months ended September 30, 2022, and its Quarterly Report on Form 10-Q for the three and six months ended and as of December 31, 2022, as soon as practicable.
Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
On March 1, 2023, the Company’s audit committee (the “Audit Committee”), based on the recommendation of, and after consultation with, the Company’s management, and as discussed with BDO USA, LLP (“BDO”), the Company’s independent registered public accounting firm for the previously issued financial statements, concluded that the Company’s audited financial statements as reported in the Company’s annual report on Form 10-K for the fiscal year ended June 30, 2022, filed with the SEC on September 1, 2022, and the financial statements as reported in the Company’s quarterly report on Form 10-Q for the period ended September 30, 2022, filed with the SEC on November 10, 2022, should no longer be relied upon due to inaccurate fair value measurements of a certain corporate investment (the “Non-Reliance Periods”).
As a result, the Company will restate its financial results for the Non-Reliance Periods to reflect the corrected fair value measurements of the investment (the “Restatements”).
Fair Value Restatements
As a result of errors detected in the fair value calculations performed by a third party, the fair value of a corporate investment in common share purchase warrants was overstated at June 30, 2022, and September 30, 2022, resulting in an understatement of investment loss and an overstatement of net income for both periods; and for the fiscal year ended June 30, 2022, an overstatement of basic and diluted earnings per share. As a result of the errors, investments in equity securities were overstated, deferred tax assets were understated, and equity was overstated as of June 30, 2022, and September 30, 2022.
Additionally, an error was detected in the fair value calculations for a corporate investment in unsecured convertible debentures, as a result, the fair value was overstated at June 30, 2022, and September 30, 2022. As a result of the error, other comprehensive income was overstated, investments in available-for-sale debt securities were overstated, deferred tax assets were understated, and equity was overstated.
The foregoing error with respect to the fair value of the corporate investment in unsecured convertible debentures also had an immaterial effect on the Company’s annual consolidated financial statements for the year ended June 30, 2021, and unaudited consolidated financial statements for the periods ended September 30, 2021, December 31, 2021, and March 31, 2022 (collectively, the “Revision Periods”). While the Audit Committee and management concluded that this accounting error had an immaterial impact on the Revision Periods, those financial statements will be revised in the June 30, 2022, Form 10-K/A.
The Company intends to, as soon as practicable, restate the consolidated financial statements for the fiscal year ended and as of June 30, 2022, on Form 10-K/A-2 and the consolidated financial statements for the three months ending and as of September 30, 2022, on Form 10-Q/A. The Company also intends to file the Quarterly Report on Form 10-Q for the three and six months ended December 31, 2022, as soon as practicable.
Management’s Report on Internal Control Over Financial Reporting
Management identified a deficiency in the design and operating effectiveness of the Company’s internal controls as of June 30, 2022, and September 30, 2022, that represents a material weakness in our internal control over financial reporting. The deficiency is the result of the inadequate design of controls to measure the fair value of the Company’s investments and overreliance on the work of a third-party specialist resulting in undetected errors in the valuation of certain investments. Management is in the process of designing and implementing remediation efforts intended to address the material weakness.
Disclosures About Forward-Looking Statements
All the above statements regarding the expected impact of the restatements constitute forward-looking statements that are based on our current expectations. The final amounts and the detailed presentation of the restatements will be included in our upcoming filings after we have completed our work on the restatements, and BDO USA, LLP have completed their review of the financial statements for the restatement period, and the Audit Committee has completed its final review of the financial statements for the restatement period. There can be no assurance that this information will not change, possibly materially, before we file the restated financial statements.
This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Report Act of 1995. All statements other than those that are purely historical are forward-looking statements. These statements are often identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “should,” “estimate,” or “continue,” and similar expressions or variations. Forward-looking statements include statements regarding expected materiality or significance, and any anticipated conclusions of the Company, the Audit Committee or management. Such forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results, as well as expectations regarding materiality or significance, the effectiveness of our disclosure controls and procedures, and our deficiencies in internal control over financial reporting to differ materially from those in the forward-looking statements.
Item 9.01 — Financial Statement and Exhibits
Exhibit 104 – Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
U.S. Global Investors, Inc.
By:/s/ Lisa Callicotte
Lisa Callicotte
CFO
|
Dated: March 6, 2023
Exhibit 99.1
|
Contact:
Holly Schoenfeldt
Director of Marketing
210.308.1268
hschoenfeldt@usfunds.com
|
|
| |
For Immediate Release |
U.S. Global Investors Continues Share Repurchases in February and Provides Update on Financial Statements
******************************************************************************
SAN ANTONIO—March 6, 2023—U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, today is pleased to announce that it repurchased 34,502 of its own shares in February 2023, at a net cost of about $108,000.
In December 2022, the Board of Directors (the “Board”) agreed to modify the Company’s buyback algorithm; the Company may now buy back shares of GROW stock when the price is flat or down from the previous trading day.
“In his most recent annual shareholder letter, Warren Buffett discusses the value of share repurchases so long as they’re made at ‘value-accretive prices.’ When shares are bought back at attractive prices, Buffett writes, they can benefit all shareholders, not just the biggest shareholders,” says Frank Holmes, the Company’s CEO and Chief Investment Officer. “Like Buffett, we seek to create value for all GROW shareholders, and our recently enhanced share buyback program is designed to do just that.”
Non-Cash Restatements
In addition, the Company announces that it will make non-cash restatements of its consolidated financial statements and related disclosures for the fiscal year ended June 30, 2022, and for the three months ended September 30, 2022, before it files its financial statements for the quarter ended December 31, 2022.
As was noted in a previous press release, the Company did not file its financial statements for the most recent quarter due to the Company’s need for additional time to determine the fair value of certain securities held as corporate investments. When determining the fair value of those securities, the Company discovered that they were measured inaccurately in financial statements for the year ended June 30, and period ended September 30, 2022.
"The December 31, 2022, valuation analysis of investments led to the discovery of an error in a third party’s fair value calculations of our warrants and in the complex binomial option pricing model for our convertible debenture. This error is a non-cash restatement and will not affect the Company’s operating revenue or cash flow provided by operating activities,” says Mr. Holmes. “The warrants and convertible debenture we hold as corporate investments are complex instruments, and the valuation method can be equally as complex. The binomial option pricing model is a lattice-based model used by an independent third party to calculate the fair value of the convertible debenture, and I encourage investors and shareholders to learn more about it by reading the Investopedia entry.”
The fair value of a corporate investment in common share purchase warrants was overstated in the Company’s financial statements for the year ended June 30, and period ended September 30, 2022. The correction of the valuation of the warrants will be a decrease in unrealized investment income, a decrease in investments, an increase in deferred tax assets and a decrease in equity as of June 30, and September 30, 2022.
The Company is working diligently to refile all financials and disclosures for these periods after it corrects the valuations of the securities. After that is complete, the Company will work to file financial statements for the three- and six-month periods ended December 31, 2022.
Mr. Holmes continues: “Please keep in mind that the process of restating past financial reports will require some time to complete. Financials for the year ended June 2022 and period ended September 2022 will need to be restated and refiled before we can report earnings for the December quarter. I look forward to sharing and discussing those earnings as soon as they’re made public.”
About U.S. Global Investors, Inc.
The story of U.S. Global Investors goes back more than 50 years when it began as an investment club. Today, U.S. Global Investors, Inc. (www.usfunds.com) is a registered investment adviser that focuses on niche markets around the world. Headquartered in San Antonio, Texas, the Company provides investment advisory services to U.S. Global Investors Funds and U.S. Global ETFs.
To sign up for news and research on a variety of asset classes, from gold to airlines to digital assets, please click here.
Follow U.S. Global Investors on Twitter by clicking here.
Subscribe to U.S. Global Investors’ YouTube channel by clicking here.
# # #
This news release may include certain “forward-looking statements” including statements relating to revenues, expenses, and expectations regarding market conditions. These statements involve certain risks and uncertainties. There can be no assurance that such statements will prove accurate and actual results and future events could differ materially from those anticipated in such statements.
